The Global Market for Clinical Diagnostics Automation is Forecast to Exceed US$6.5 Billion by 2024
Rise in Annual Test Volumes &
Growing Need to Improve Productivity Drive Adoption of Clinical Diagnostics
Automation, According to a New Report
by Global
Industry Analysts, Inc.
GIA
launches comprehensive analysis of industry segments, trends, growth drivers,
market share, size and demand forecasts on the global Clinical Diagnostics
Automation market. The global market for
Clinical Diagnostics Automation is forecast to exceed US$6.5 billion by 2024, driven by rise in annual test
volumes and growing focus of laboratories to increase turnaround times, improve
workflow efficiency and reduce operational costs.
.
Clinical
diagnostic procedures have hitherto been manually-performed procedures, but
automation in recent years has revolutionized the diagnosis industry. Automated
testing is exponentially faster and provides results with very high accuracy,
leading to lower treatment costs and higher survival rates. Automation is
emerging as an essential requirement for labs, as they look to improve
workflows to meet the demands arising from the increase in number of diagnostic
tests performed. Growth would also be spurred by the immediate need of medical
labs to automate lab processes, not only to increase capacity of clinical lab
testing but also to enhance productivity. Shortage of trained technologists is
a major factor driving the shift towards automation in clinical diagnostic
laboratories. Increase in annual testing volumes due to aging global
population, diagnostic and testing procedure innovations, and emerging
challenges in the form of detection and identification of multidrug-resistant
microorganisms are further driving demand for automation of clinical
diagnostics in laboratories.
Overall,
demand is on rise for flexible automation solutions, given the rising cost and
complexity associated with the process of automation. A significant trend
impacting the lab automation systems market is the reduction in sample load
volumes to microliters and nanoliters. Some of the new automated systems
integrate pre-analytical and analytical stages involved in sample processing
and offer actionable results, while minimizing the potential for human errors. Trend
towards automation, particularly modular automation among laboratories, is
expected to fuel demand for standardized interfaces, thereby facilitating
instruments manufactured by different vendors to be connected as well as
operated together.
Modular
systems of laboratory automation are emerging as ideal alternatives to total
laboratory automation (TLA), due to small-scale implementation, flexibility,
and small investment.
As
stated by the new market research report on Clinical Diagnostics
Automation,
the United States represents the single largest market worldwide. Asia-Pacific
is forecast to register fastest growth at a CAGR of 12.4% over the analysis
period. Growth in the market is led by factors such as growing focus on
improving healthcare services, emphasis on controlling costs of public
hospitals, continuous rise in number of patients at primary healthcare centers,
and rapid growth of private hospitals
Major
players in the market include Abaxis Inc., Abbott Diagnostics Inc., Beckman
Coulter Inc., Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories
Inc., Diagnostica Stago, Eppendorf AG, F Hoffmann-La Roche Ltd., HORIBA ABX
SAS, Hudson Robotics Inc., Ortho Clinical Diagnostics Inc., PerkinElmer Inc.,
QIAGEN NV, Siemens Healthineers, Sysmex America Inc., Tecan Group Ltd., The
ELITechGroup SAS, and Thermo Fisher Scientific Inc., among others.
The
research report titled “Clinical Diagnostics
Automation: A Global Strategic Business Report” announced by Global
Industry Analysts Inc., provides a comprehensive review of market trends,
growth drivers, regulations, issues, challenges, mergers, acquisitions, and
other strategic industry activities of major players worldwide. The report
provides market estimates and projections in dollars for all major geographic
markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK,
Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of
Asia-Pacific), Latin America (Brazil and Rest of Latin America), and Rest of
World. Segments analyzed include Automated Analyzers, Total Lab Automation and
Stand-alone Automation.
For
enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.
To
connect with us, visit our LinkedIn page.
Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA,
All Rights Reserved.
Comments
Post a Comment